Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors
Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we investigated the genomic and transcriptomic alterations in matching adjacent normal tissues, primary tumors, and metastatic tumors of CRC...
Saved in:
| Published in | Genome medicine Vol. 14; no. 1; pp. 93 - 26 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
16.08.2022
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we investigated the genomic and transcriptomic alterations in matching adjacent normal tissues, primary tumors, and metastatic tumors of CRC patients.
We performed whole genome sequencing (WGS), multi-region whole exome sequencing (WES), simultaneous single-cell RNA-Seq, and single-cell targeted cDNA Sanger sequencing on matching adjacent normal tissues, primary tumors, and metastatic tumors from 12 metastatic colorectal cancer patients (n=84 for genomes, n=81 for exomes, n=9120 for single cells). Patient-derived tumor organoids were used to estimate the anti-tumor effects of a PPAR inhibitor, and self-renewal and differentiation ability of stem cell-like tumor cells.
We found that the PPAR signaling pathway was prevalently and aberrantly activated in CRC tumors. Blocking of PPAR pathway both suppressed the growth and promoted the apoptosis of CRC organoids in vitro, indicating that aberrant activation of the PPAR signaling pathway plays a critical role in CRC tumorigenesis. Using matched samples from the same patient, distinct origins of the metastasized tumors between lymph node and liver were revealed, which was further verified by both copy number variation and mitochondrial mutation profiles at single-cell resolution. By combining single-cell RNA-Seq and single-cell point mutation identification by targeted cDNA Sanger sequencing, we revealed important phenotypic differences between cancer cells with and without critical point mutations (KRAS and TP53) in the same patient in vivo at single-cell resolution.
Our data provides deep insights into how driver mutations interfere with the transcriptomic state of cancer cells in vivo at a single-cell resolution. Our findings offer novel knowledge on metastatic mechanisms as well as potential markers and therapeutic targets for CRC diagnosis and therapy. The high-precision single-cell RNA-seq dataset of matched adjacent normal tissues, primary tumors, and metastases from CRCs may serve as a rich resource for further studies. |
|---|---|
| AbstractList | Background Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we investigated the genomic and transcriptomic alterations in matching adjacent normal tissues, primary tumors, and metastatic tumors of CRC patients. Methods We performed whole genome sequencing (WGS), multi-region whole exome sequencing (WES), simultaneous single-cell RNA-Seq, and single-cell targeted cDNA Sanger sequencing on matching adjacent normal tissues, primary tumors, and metastatic tumors from 12 metastatic colorectal cancer patients (n=84 for genomes, n=81 for exomes, n=9120 for single cells). Patient-derived tumor organoids were used to estimate the anti-tumor effects of a PPAR inhibitor, and self-renewal and differentiation ability of stem cell-like tumor cells. Results We found that the PPAR signaling pathway was prevalently and aberrantly activated in CRC tumors. Blocking of PPAR pathway both suppressed the growth and promoted the apoptosis of CRC organoids in vitro, indicating that aberrant activation of the PPAR signaling pathway plays a critical role in CRC tumorigenesis. Using matched samples from the same patient, distinct origins of the metastasized tumors between lymph node and liver were revealed, which was further verified by both copy number variation and mitochondrial mutation profiles at single-cell resolution. By combining single-cell RNA-Seq and single-cell point mutation identification by targeted cDNA Sanger sequencing, we revealed important phenotypic differences between cancer cells with and without critical point mutations (KRAS and TP53) in the same patient in vivo at single-cell resolution. Conclusions Our data provides deep insights into how driver mutations interfere with the transcriptomic state of cancer cells in vivo at a single-cell resolution. Our findings offer novel knowledge on metastatic mechanisms as well as potential markers and therapeutic targets for CRC diagnosis and therapy. The high-precision single-cell RNA-seq dataset of matched adjacent normal tissues, primary tumors, and metastases from CRCs may serve as a rich resource for further studies. Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we investigated the genomic and transcriptomic alterations in matching adjacent normal tissues, primary tumors, and metastatic tumors of CRC patients. We performed whole genome sequencing (WGS), multi-region whole exome sequencing (WES), simultaneous single-cell RNA-Seq, and single-cell targeted cDNA Sanger sequencing on matching adjacent normal tissues, primary tumors, and metastatic tumors from 12 metastatic colorectal cancer patients (n=84 for genomes, n=81 for exomes, n=9120 for single cells). Patient-derived tumor organoids were used to estimate the anti-tumor effects of a PPAR inhibitor, and self-renewal and differentiation ability of stem cell-like tumor cells. We found that the PPAR signaling pathway was prevalently and aberrantly activated in CRC tumors. Blocking of PPAR pathway both suppressed the growth and promoted the apoptosis of CRC organoids in vitro, indicating that aberrant activation of the PPAR signaling pathway plays a critical role in CRC tumorigenesis. Using matched samples from the same patient, distinct origins of the metastasized tumors between lymph node and liver were revealed, which was further verified by both copy number variation and mitochondrial mutation profiles at single-cell resolution. By combining single-cell RNA-Seq and single-cell point mutation identification by targeted cDNA Sanger sequencing, we revealed important phenotypic differences between cancer cells with and without critical point mutations (KRAS and TP53) in the same patient in vivo at single-cell resolution. Our data provides deep insights into how driver mutations interfere with the transcriptomic state of cancer cells in vivo at a single-cell resolution. Our findings offer novel knowledge on metastatic mechanisms as well as potential markers and therapeutic targets for CRC diagnosis and therapy. The high-precision single-cell RNA-seq dataset of matched adjacent normal tissues, primary tumors, and metastases from CRCs may serve as a rich resource for further studies. Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we investigated the genomic and transcriptomic alterations in matching adjacent normal tissues, primary tumors, and metastatic tumors of CRC patients. We performed whole genome sequencing (WGS), multi-region whole exome sequencing (WES), simultaneous single-cell RNA-Seq, and single-cell targeted cDNA Sanger sequencing on matching adjacent normal tissues, primary tumors, and metastatic tumors from 12 metastatic colorectal cancer patients (n=84 for genomes, n=81 for exomes, n=9120 for single cells). Patient-derived tumor organoids were used to estimate the anti-tumor effects of a PPAR inhibitor, and self-renewal and differentiation ability of stem cell-like tumor cells. We found that the PPAR signaling pathway was prevalently and aberrantly activated in CRC tumors. Blocking of PPAR pathway both suppressed the growth and promoted the apoptosis of CRC organoids in vitro, indicating that aberrant activation of the PPAR signaling pathway plays a critical role in CRC tumorigenesis. Using matched samples from the same patient, distinct origins of the metastasized tumors between lymph node and liver were revealed, which was further verified by both copy number variation and mitochondrial mutation profiles at single-cell resolution. By combining single-cell RNA-Seq and single-cell point mutation identification by targeted cDNA Sanger sequencing, we revealed important phenotypic differences between cancer cells with and without critical point mutations (KRAS and TP53) in the same patient in vivo at single-cell resolution. Our data provides deep insights into how driver mutations interfere with the transcriptomic state of cancer cells in vivo at a single-cell resolution. Our findings offer novel knowledge on metastatic mechanisms as well as potential markers and therapeutic targets for CRC diagnosis and therapy. The high-precision single-cell RNA-seq dataset of matched adjacent normal tissues, primary tumors, and metastases from CRCs may serve as a rich resource for further studies. Background Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we investigated the genomic and transcriptomic alterations in matching adjacent normal tissues, primary tumors, and metastatic tumors of CRC patients. Methods We performed whole genome sequencing (WGS), multi-region whole exome sequencing (WES), simultaneous single-cell RNA-Seq, and single-cell targeted cDNA Sanger sequencing on matching adjacent normal tissues, primary tumors, and metastatic tumors from 12 metastatic colorectal cancer patients (n=84 for genomes, n=81 for exomes, n=9120 for single cells). Patient-derived tumor organoids were used to estimate the anti-tumor effects of a PPAR inhibitor, and self-renewal and differentiation ability of stem cell-like tumor cells. Results We found that the PPAR signaling pathway was prevalently and aberrantly activated in CRC tumors. Blocking of PPAR pathway both suppressed the growth and promoted the apoptosis of CRC organoids in vitro, indicating that aberrant activation of the PPAR signaling pathway plays a critical role in CRC tumorigenesis. Using matched samples from the same patient, distinct origins of the metastasized tumors between lymph node and liver were revealed, which was further verified by both copy number variation and mitochondrial mutation profiles at single-cell resolution. By combining single-cell RNA-Seq and single-cell point mutation identification by targeted cDNA Sanger sequencing, we revealed important phenotypic differences between cancer cells with and without critical point mutations (KRAS and TP53) in the same patient in vivo at single-cell resolution. Conclusions Our data provides deep insights into how driver mutations interfere with the transcriptomic state of cancer cells in vivo at a single-cell resolution. Our findings offer novel knowledge on metastatic mechanisms as well as potential markers and therapeutic targets for CRC diagnosis and therapy. The high-precision single-cell RNA-seq dataset of matched adjacent normal tissues, primary tumors, and metastases from CRCs may serve as a rich resource for further studies. Keywords: Metastatic colorectal cancer, Single-cell transcriptome profiling, Lineage tracing, Genotype-phenotype relationship, Mitochondrial mutations, Patient-derived organoids, PPAR signaling pathway Abstract Background Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we investigated the genomic and transcriptomic alterations in matching adjacent normal tissues, primary tumors, and metastatic tumors of CRC patients. Methods We performed whole genome sequencing (WGS), multi-region whole exome sequencing (WES), simultaneous single-cell RNA-Seq, and single-cell targeted cDNA Sanger sequencing on matching adjacent normal tissues, primary tumors, and metastatic tumors from 12 metastatic colorectal cancer patients (n=84 for genomes, n=81 for exomes, n=9120 for single cells). Patient-derived tumor organoids were used to estimate the anti-tumor effects of a PPAR inhibitor, and self-renewal and differentiation ability of stem cell-like tumor cells. Results We found that the PPAR signaling pathway was prevalently and aberrantly activated in CRC tumors. Blocking of PPAR pathway both suppressed the growth and promoted the apoptosis of CRC organoids in vitro, indicating that aberrant activation of the PPAR signaling pathway plays a critical role in CRC tumorigenesis. Using matched samples from the same patient, distinct origins of the metastasized tumors between lymph node and liver were revealed, which was further verified by both copy number variation and mitochondrial mutation profiles at single-cell resolution. By combining single-cell RNA-Seq and single-cell point mutation identification by targeted cDNA Sanger sequencing, we revealed important phenotypic differences between cancer cells with and without critical point mutations (KRAS and TP53) in the same patient in vivo at single-cell resolution. Conclusions Our data provides deep insights into how driver mutations interfere with the transcriptomic state of cancer cells in vivo at a single-cell resolution. Our findings offer novel knowledge on metastatic mechanisms as well as potential markers and therapeutic targets for CRC diagnosis and therapy. The high-precision single-cell RNA-seq dataset of matched adjacent normal tissues, primary tumors, and metastases from CRCs may serve as a rich resource for further studies. Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we investigated the genomic and transcriptomic alterations in matching adjacent normal tissues, primary tumors, and metastatic tumors of CRC patients.BACKGROUNDColorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we investigated the genomic and transcriptomic alterations in matching adjacent normal tissues, primary tumors, and metastatic tumors of CRC patients.We performed whole genome sequencing (WGS), multi-region whole exome sequencing (WES), simultaneous single-cell RNA-Seq, and single-cell targeted cDNA Sanger sequencing on matching adjacent normal tissues, primary tumors, and metastatic tumors from 12 metastatic colorectal cancer patients (n=84 for genomes, n=81 for exomes, n=9120 for single cells). Patient-derived tumor organoids were used to estimate the anti-tumor effects of a PPAR inhibitor, and self-renewal and differentiation ability of stem cell-like tumor cells.METHODSWe performed whole genome sequencing (WGS), multi-region whole exome sequencing (WES), simultaneous single-cell RNA-Seq, and single-cell targeted cDNA Sanger sequencing on matching adjacent normal tissues, primary tumors, and metastatic tumors from 12 metastatic colorectal cancer patients (n=84 for genomes, n=81 for exomes, n=9120 for single cells). Patient-derived tumor organoids were used to estimate the anti-tumor effects of a PPAR inhibitor, and self-renewal and differentiation ability of stem cell-like tumor cells.We found that the PPAR signaling pathway was prevalently and aberrantly activated in CRC tumors. Blocking of PPAR pathway both suppressed the growth and promoted the apoptosis of CRC organoids in vitro, indicating that aberrant activation of the PPAR signaling pathway plays a critical role in CRC tumorigenesis. Using matched samples from the same patient, distinct origins of the metastasized tumors between lymph node and liver were revealed, which was further verified by both copy number variation and mitochondrial mutation profiles at single-cell resolution. By combining single-cell RNA-Seq and single-cell point mutation identification by targeted cDNA Sanger sequencing, we revealed important phenotypic differences between cancer cells with and without critical point mutations (KRAS and TP53) in the same patient in vivo at single-cell resolution.RESULTSWe found that the PPAR signaling pathway was prevalently and aberrantly activated in CRC tumors. Blocking of PPAR pathway both suppressed the growth and promoted the apoptosis of CRC organoids in vitro, indicating that aberrant activation of the PPAR signaling pathway plays a critical role in CRC tumorigenesis. Using matched samples from the same patient, distinct origins of the metastasized tumors between lymph node and liver were revealed, which was further verified by both copy number variation and mitochondrial mutation profiles at single-cell resolution. By combining single-cell RNA-Seq and single-cell point mutation identification by targeted cDNA Sanger sequencing, we revealed important phenotypic differences between cancer cells with and without critical point mutations (KRAS and TP53) in the same patient in vivo at single-cell resolution.Our data provides deep insights into how driver mutations interfere with the transcriptomic state of cancer cells in vivo at a single-cell resolution. Our findings offer novel knowledge on metastatic mechanisms as well as potential markers and therapeutic targets for CRC diagnosis and therapy. The high-precision single-cell RNA-seq dataset of matched adjacent normal tissues, primary tumors, and metastases from CRCs may serve as a rich resource for further studies.CONCLUSIONSOur data provides deep insights into how driver mutations interfere with the transcriptomic state of cancer cells in vivo at a single-cell resolution. Our findings offer novel knowledge on metastatic mechanisms as well as potential markers and therapeutic targets for CRC diagnosis and therapy. The high-precision single-cell RNA-seq dataset of matched adjacent normal tissues, primary tumors, and metastases from CRCs may serve as a rich resource for further studies. |
| ArticleNumber | 93 |
| Audience | Academic |
| Author | Chen, Kexuan Gao, Shuai Tang, Fuchou Yu, Shuntai Wu, Xinglong Wang, Wei Wen, Lu Wang, Wendong Zhou, Xin Ge, Hao Li, Jingyun Mao, Yunuo Wang, Rui Fu, Wei Gao, Yuan |
| Author_xml | – sequence: 1 givenname: Rui surname: Wang fullname: Wang, Rui – sequence: 2 givenname: Jingyun surname: Li fullname: Li, Jingyun – sequence: 3 givenname: Xin surname: Zhou fullname: Zhou, Xin – sequence: 4 givenname: Yunuo surname: Mao fullname: Mao, Yunuo – sequence: 5 givenname: Wendong surname: Wang fullname: Wang, Wendong – sequence: 6 givenname: Shuai surname: Gao fullname: Gao, Shuai – sequence: 7 givenname: Wei surname: Wang fullname: Wang, Wei – sequence: 8 givenname: Yuan surname: Gao fullname: Gao, Yuan – sequence: 9 givenname: Kexuan surname: Chen fullname: Chen, Kexuan – sequence: 10 givenname: Shuntai surname: Yu fullname: Yu, Shuntai – sequence: 11 givenname: Xinglong surname: Wu fullname: Wu, Xinglong – sequence: 12 givenname: Lu surname: Wen fullname: Wen, Lu – sequence: 13 givenname: Hao surname: Ge fullname: Ge, Hao – sequence: 14 givenname: Wei surname: Fu fullname: Fu, Wei – sequence: 15 givenname: Fuchou surname: Tang fullname: Tang, Fuchou |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35974387$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kl1rFDEUhgep2Hb1D3ghA4J4MzXfmdwIpfhRKHihgnchkzmzm5JN1mSmYH-9md217haRXCScPOdN8uY9r05CDFBVLzG6wLgV7zKmSNIGEdIgjBRt7p9UZ1hy0SjFfpwcrE-r85xvERKMMPmsOqVcSUZbeVb1X11YemgseF8vIcS1s7UJfT0mE7JNbjNuS77UsjUbyHUc6k1ya5N-bcE1jCaPZiyQjT4msKPxtTXBQqrHaR1Tfl49HYzP8GI_L6rvHz98u_rc3Hz5dH11edNYrtjYUMWUIi3tGUEUOKGMSq64lAI4JYy1VMrOEDIMRLbCtlgJCWCZ6CnBVg10UV3vdPtobvX-kjoap7eFmJbapHJRD1q2iggrsKQDsLLqOgS0o52VwlrOWdF6v9PaTN0aeguhOOKPRI93glvpZbzTiraIllcsqrd7gRR_TpBHvXZ5ttkEiFPWRCLKcEvFfNbrR-htnFIoVs0UQ7x8FvpLLU15gAtDLOfaWVRfStxiwSWXhbr4B1VGD-UfS4AGV-pHDW8OGlZg_LjK0U-jiyEfg68OHXmw4k-YCkB2gE0x5wTDA4KRnhOrd4nVJbF6m1h9X5raR03WzWmKs6vO_6_1N0Aj7fw |
| CitedBy_id | crossref_primary_10_3389_fphar_2023_1169566 crossref_primary_10_3390_cimb46110744 crossref_primary_10_1177_15330338231185285 crossref_primary_10_1186_s13073_022_01093_z crossref_primary_10_3389_fmolb_2024_1469775 crossref_primary_10_1002_cam4_70819 crossref_primary_10_1186_s12864_024_10928_5 crossref_primary_10_3389_fimmu_2025_1556386 crossref_primary_10_1016_j_neucom_2024_127498 crossref_primary_10_3390_cancers16050927 crossref_primary_10_3748_wjg_v29_i9_1395 crossref_primary_10_4251_wjgo_v16_i6_2683 crossref_primary_10_2147_CMAR_S441675 crossref_primary_10_1007_s12672_024_01424_z crossref_primary_10_1038_s41420_024_02025_z crossref_primary_10_18137_cardiometry_2024_33_conf_12 crossref_primary_10_3390_cancers14194833 crossref_primary_10_1016_j_tranon_2024_102039 crossref_primary_10_1245_s10434_024_16334_1 crossref_primary_10_1038_s41420_025_02313_2 crossref_primary_10_1038_s41416_024_02634_6 crossref_primary_10_1016_j_theriogenology_2024_10_010 crossref_primary_10_3390_genes16010013 crossref_primary_10_3390_gidisord5040046 crossref_primary_10_1186_s12967_023_03879_0 crossref_primary_10_1186_s13073_023_01229_9 crossref_primary_10_1186_s12885_023_10816_3 crossref_primary_10_1371_journal_pone_0318776 crossref_primary_10_3389_fimmu_2024_1356075 crossref_primary_10_1186_s13045_023_01494_6 crossref_primary_10_1245_s10434_024_16194_9 crossref_primary_10_1016_j_heliyon_2023_e14132 crossref_primary_10_1126_sciadv_adn0220 crossref_primary_10_32604_or_2022_027900 crossref_primary_10_1016_j_jep_2024_117995 crossref_primary_10_1007_s10238_024_01378_0 crossref_primary_10_1016_j_cbd_2024_101282 crossref_primary_10_1016_j_intimp_2024_113033 crossref_primary_10_1016_j_wneu_2024_09_138 crossref_primary_10_1038_s41571_024_00926_7 crossref_primary_10_1038_s12276_023_01011_2 crossref_primary_10_5306_wjco_v15_i1_89 crossref_primary_10_1007_s10555_024_10189_4 crossref_primary_10_3389_fgene_2023_1223913 crossref_primary_10_1016_j_cej_2024_154600 crossref_primary_10_1016_j_xcrm_2024_101838 crossref_primary_10_1002_1878_0261_13785 crossref_primary_10_3390_jpm14010108 crossref_primary_10_1097_MD_0000000000039592 crossref_primary_10_1038_s41598_025_90899_z crossref_primary_10_3892_ol_2023_13914 crossref_primary_10_1021_acs_jproteome_5c00010 crossref_primary_10_1016_j_tranon_2024_102011 crossref_primary_10_1038_s43018_024_00807_z crossref_primary_10_1111_jcmm_70142 crossref_primary_10_1186_s12943_024_02171_z crossref_primary_10_3389_fonc_2023_1222932 crossref_primary_10_1186_s12959_024_00647_y crossref_primary_10_1186_s13287_024_03768_3 crossref_primary_10_1016_j_biomaterials_2025_123095 crossref_primary_10_1186_s13148_023_01574_x crossref_primary_10_1016_j_heliyon_2024_e30277 |
| Cites_doi | 10.1038/s41586-019-1672-7 10.1038/nbt.3192 10.1093/bioinformatics/btp120 10.1038/s41586-020-2477-4 10.1186/s13073-022-01093-z 10.1093/bioinformatics/btw777 10.1371/journal.pgen.1005778 10.1016/j.jcmgh.2017.01.006 10.1002/0471250953.bi1110s43 10.1016/j.stem.2015.05.016 10.1101/gr.209973.116 10.4161/fly.19695 10.7554/eLife.10769 10.1155/2012/876418 10.1038/nature11252 10.1186/s12935-020-1117-2 10.1038/nature10166 10.1126/science.aao3791 10.1038/s41586-019-1670-9 10.1038/nature19768 10.1038/sj.bjp.0705973 10.1038/srep29765 10.1038/s41591-019-0652-7 10.1038/nri.2017.103 10.1155/2012/242498 10.1245/s10434-007-9746-4 10.1126/science.aai8515 10.1016/j.cell.2019.03.026 10.1038/nmeth.4463 10.1038/cr.2016.23 10.1158/1535-7163.MCT-09-0214 10.1038/emboj.2010.343 10.1038/sj.onc.1206192 10.1038/s41588-020-0633-2 10.1126/science.1262110 10.1101/gr.110882.110 10.1038/ng.3818 10.1186/s12885-017-3777-4 10.1093/bioinformatics/btu638 10.1093/bioinformatics/bty633 10.3322/caac.21551 10.1038/nprot.2014.006 10.3322/caac.21492 10.1002/ijc.31785 10.1158/1541-7786.MCR-19-0144 |
| ContentType | Journal Article |
| Copyright | 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022 |
| Copyright_xml | – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s13073-022-01093-z |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database ProQuest Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1756-994X |
| EndPage | 26 |
| ExternalDocumentID | oai_doaj_org_article_78926c6173fe426cbb0e3b3bc76cc554 PMC9380328 A718165757 35974387 10_1186_s13073_022_01093_z |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- 0R~ 2WC 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACJQM ACUHS ADUKV AENEX AFKRA AFPKN AHBYD AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIAM BBNVY BENPR BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION DIK E3Z EBD EBLON EBS ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR IHW INH INR ITC KQ8 LK8 M1P M7P MK0 M~E O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SBL SOJ TUS UKHRP CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB PMFND 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c594t-39499283d4203e523437595776e532448377ba22ff2786c81967eec46d321c9f3 |
| IEDL.DBID | 7X7 |
| ISSN | 1756-994X |
| IngestDate | Wed Aug 27 01:30:37 EDT 2025 Thu Aug 21 18:35:13 EDT 2025 Mon Jul 21 09:24:51 EDT 2025 Fri Jul 25 09:13:18 EDT 2025 Tue Jun 17 21:37:23 EDT 2025 Tue Jun 10 20:08:06 EDT 2025 Thu May 22 21:14:26 EDT 2025 Mon Jul 21 06:04:29 EDT 2025 Tue Jul 01 04:01:12 EDT 2025 Thu Apr 24 23:12:25 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Genotype-phenotype relationship Patient-derived organoids Mitochondrial mutations Lineage tracing Single-cell transcriptome profiling Metastatic colorectal cancer PPAR signaling pathway |
| Language | English |
| License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c594t-39499283d4203e523437595776e532448377ba22ff2786c81967eec46d321c9f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2704057430?pq-origsite=%requestingapplication% |
| PMID | 35974387 |
| PQID | 2704057430 |
| PQPubID | 2040231 |
| PageCount | 26 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_78926c6173fe426cbb0e3b3bc76cc554 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9380328 proquest_miscellaneous_2703418364 proquest_journals_2704057430 gale_infotracmisc_A718165757 gale_infotracacademiconefile_A718165757 gale_healthsolutions_A718165757 pubmed_primary_35974387 crossref_primary_10_1186_s13073_022_01093_z crossref_citationtrail_10_1186_s13073_022_01093_z |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-08-16 |
| PublicationDateYYYYMMDD | 2022-08-16 |
| PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-16 day: 16 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Genome medicine |
| PublicationTitleAlternate | Genome Med |
| PublicationYear | 2022 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | NPM Brouwer (1093_CR5) 2018; 143 JI Park (1093_CR34) 2012; 2012 MT Goswami (1093_CR42) 2019; 17 M Liu (1093_CR6) 2017; 17 1093_CR25 1093_CR26 Consortium GT (1093_CR40) 2015; 348 P Razavi (1093_CR12) 2019; 25 R Uchi (1093_CR19) 2016; 12 A Fucci (1093_CR35) 2012; 2012 S Aibar (1093_CR31) 2017; 14 JM Seargent (1093_CR37) 2004; 143 M Zhu (1093_CR15) 2019; 177 F Blokzijl (1093_CR16) 2016; 538 S Islam (1093_CR20) 2011; 21 S Picelli (1093_CR21) 2014; 9 BY Mok (1093_CR46) 2020; 583 DJ McCarthy (1093_CR29) 2017; 33 R Satija (1093_CR30) 2015; 33 S Bian (1093_CR11) 2018; 362 H Kwak (1093_CR36) 2009; 8 F Bray (1093_CR1) 2018; 68 HP Li (1093_CR18) 2017; 49 Cancer Genome Atlas N (1093_CR9) 2012; 487 GA Van der Auwera (1093_CR23) 2013; 43 Z Wu (1093_CR10) 2015; 17 SF Brunner (1093_CR14) 2019; 574 C Trapnell (1093_CR27) 2009; 25 H Lee-Six (1093_CR13) 2019; 574 M Srinivasan (1093_CR41) 2011; 30 K Motoyama (1093_CR44) 2008; 15 1093_CR49 ML Leung (1093_CR17) 2017; 27 LR Zarour (1093_CR4) 2017; 3 Y Hou (1093_CR32) 2016; 26 JG Reiter (1093_CR48) 2020; 52 LS Ludwig (1093_CR38) 2019; 176 J Li (1093_CR45) 2003; 22 GN Fanelli (1093_CR43) 2020; 20 CT Taylor (1093_CR47) 2017; 17 K Naxerova (1093_CR7) 2017; 357 R Yaeger (1093_CR8) 2018; 33 Cancer Genome Atlas Research N (1093_CR22) 2011; 474 RL Siegel (1093_CR2) 2019; 69 M Riihimaki (1093_CR3) 2016; 6 S Anders (1093_CR28) 2015; 31 E Paradis (1093_CR33) 2019; 35 E Reznik (1093_CR39) 2016; 5 P Cingolani (1093_CR24) 2012; 6 |
| References_xml | – volume: 574 start-page: 532 year: 2019 ident: 1093_CR13 publication-title: Nature doi: 10.1038/s41586-019-1672-7 – volume: 33 start-page: 495 year: 2015 ident: 1093_CR30 publication-title: Nat Biotechnol doi: 10.1038/nbt.3192 – volume: 25 start-page: 1105 year: 2009 ident: 1093_CR27 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp120 – volume: 583 start-page: 631 year: 2020 ident: 1093_CR46 publication-title: Nature doi: 10.1038/s41586-020-2477-4 – ident: 1093_CR26 doi: 10.1186/s13073-022-01093-z – volume: 33 start-page: 1179 year: 2017 ident: 1093_CR29 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw777 – volume: 12 start-page: e1005778 issue: 2 year: 2016 ident: 1093_CR19 publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1005778 – volume: 3 start-page: 163 year: 2017 ident: 1093_CR4 publication-title: Cell Mol Gastroenterol Hepatol doi: 10.1016/j.jcmgh.2017.01.006 – volume: 43 start-page: 11 10 11-11 10 year: 2013 ident: 1093_CR23 publication-title: Curr Protoc Bioinformatics doi: 10.1002/0471250953.bi1110s43 – volume: 17 start-page: 47 year: 2015 ident: 1093_CR10 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2015.05.016 – volume: 27 start-page: 1287 year: 2017 ident: 1093_CR17 publication-title: Genome Res doi: 10.1101/gr.209973.116 – volume: 6 start-page: 80 year: 2012 ident: 1093_CR24 publication-title: Fly (Austin) doi: 10.4161/fly.19695 – volume: 5 start-page: e10769 year: 2016 ident: 1093_CR39 publication-title: Elife. doi: 10.7554/eLife.10769 – volume: 2012 year: 2012 ident: 1093_CR34 publication-title: PPAR Res doi: 10.1155/2012/876418 – volume: 487 start-page: 330 year: 2012 ident: 1093_CR9 publication-title: Nature doi: 10.1038/nature11252 – volume: 20 start-page: 30 year: 2020 ident: 1093_CR43 publication-title: Cancer Cell Int doi: 10.1186/s12935-020-1117-2 – volume: 474 start-page: 609 year: 2011 ident: 1093_CR22 publication-title: Nature doi: 10.1038/nature10166 – volume: 362 start-page: 1060 year: 2018 ident: 1093_CR11 publication-title: Science doi: 10.1126/science.aao3791 – volume: 574 start-page: 538 year: 2019 ident: 1093_CR14 publication-title: Nature doi: 10.1038/s41586-019-1670-9 – volume: 538 start-page: 260 year: 2016 ident: 1093_CR16 publication-title: Nature doi: 10.1038/nature19768 – volume: 143 start-page: 933 year: 2004 ident: 1093_CR37 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0705973 – volume: 6 start-page: 29765 year: 2016 ident: 1093_CR3 publication-title: Sci Rep doi: 10.1038/srep29765 – volume: 25 start-page: 1927 issue: 12 year: 2019 ident: 1093_CR12 publication-title: Nat Med. doi: 10.1038/s41591-019-0652-7 – volume: 17 start-page: 774 year: 2017 ident: 1093_CR47 publication-title: Nat Rev Immunol doi: 10.1038/nri.2017.103 – volume: 2012 year: 2012 ident: 1093_CR35 publication-title: PPAR Res doi: 10.1155/2012/242498 – volume: 15 start-page: 1530 year: 2008 ident: 1093_CR44 publication-title: Ann Surg Oncol doi: 10.1245/s10434-007-9746-4 – volume: 357 start-page: 55 year: 2017 ident: 1093_CR7 publication-title: Science doi: 10.1126/science.aai8515 – volume: 177 start-page: 608 year: 2019 ident: 1093_CR15 publication-title: Cell doi: 10.1016/j.cell.2019.03.026 – volume: 14 start-page: 1083 year: 2017 ident: 1093_CR31 publication-title: Nat Methods doi: 10.1038/nmeth.4463 – volume: 26 start-page: 304 year: 2016 ident: 1093_CR32 publication-title: Cell Res doi: 10.1038/cr.2016.23 – volume: 8 start-page: 2664 year: 2009 ident: 1093_CR36 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-09-0214 – volume: 30 start-page: 873 year: 2011 ident: 1093_CR41 publication-title: EMBO J doi: 10.1038/emboj.2010.343 – volume: 176 issue: 1325-1339 year: 2019 ident: 1093_CR38 publication-title: Cell – volume: 22 start-page: 1243 year: 2003 ident: 1093_CR45 publication-title: Oncogene doi: 10.1038/sj.onc.1206192 – volume: 52 start-page: 692 year: 2020 ident: 1093_CR48 publication-title: Nat Genet doi: 10.1038/s41588-020-0633-2 – volume: 33 issue: 125-136 year: 2018 ident: 1093_CR8 publication-title: Cancer Cell – volume: 348 start-page: 648 year: 2015 ident: 1093_CR40 publication-title: Science doi: 10.1126/science.1262110 – volume: 21 start-page: 1160 year: 2011 ident: 1093_CR20 publication-title: Genome Res doi: 10.1101/gr.110882.110 – volume: 49 start-page: 708 year: 2017 ident: 1093_CR18 publication-title: Nat Genet doi: 10.1038/ng.3818 – volume: 17 start-page: 787 year: 2017 ident: 1093_CR6 publication-title: BMC Cancer doi: 10.1186/s12885-017-3777-4 – volume: 31 start-page: 166 year: 2015 ident: 1093_CR28 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu638 – ident: 1093_CR49 doi: 10.1186/s13073-022-01093-z – volume: 35 start-page: 526 year: 2019 ident: 1093_CR33 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty633 – volume: 69 start-page: 7 year: 2019 ident: 1093_CR2 publication-title: CA Cancer J Clin doi: 10.3322/caac.21551 – volume: 9 start-page: 171 year: 2014 ident: 1093_CR21 publication-title: Nat Protoc doi: 10.1038/nprot.2014.006 – ident: 1093_CR25 doi: 10.1186/s13073-022-01093-z – volume: 68 start-page: 394 year: 2018 ident: 1093_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21492 – volume: 143 start-page: 2758 year: 2018 ident: 1093_CR5 publication-title: Int J Cancer doi: 10.1002/ijc.31785 – volume: 17 start-page: 1652 year: 2019 ident: 1093_CR42 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-19-0144 |
| SSID | ssj0064247 |
| Score | 2.558365 |
| Snippet | Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here,... Background Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related... Abstract Background Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 93 |
| SubjectTerms | Apoptosis Cancer Cell differentiation Cell self-renewal Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - genetics Colorectal Neoplasms - pathology Copy number DNA Copy Number Variations DNA sequencing DNA, Complementary Gene expression Gene mutations Genetic aspects Genomes Genomics Genotype-phenotype relationship Health aspects Humans Lineage tracing Liver Lymph nodes Lymphatic system Metastases Metastasis Metastatic colorectal cancer Microscopy Mitochondria Mitochondrial mutations Mutation Neoplasm Metastasis Nucleotide sequencing Oncology, Experimental Organoids Patient-derived organoids Patients Peroxisome proliferator-activated receptors Peroxisome Proliferator-Activated Receptors - antagonists & inhibitors Peroxisome Proliferator-Activated Receptors - genetics Point mutation Ribonucleic acid RNA RNA sequencing Signal transduction Single-cell transcriptome profiling Stem cells Therapeutic targets Transcriptome Transcriptomics Tumor cells Tumor proteins Tumorigenesis Tumors Whole genome sequencing |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9QwFA-yIHgRv62uWkHwIGHbpM3HcRWXRdCLLuwtJK8pLux0lpnOwf3rfS_plCmCXrw2rzPJ-07z3i-MvcOUNviusnSqG-lrVeDeQsvBNqqrbTRRUHPy12_q_KL5ctleHlz1RTVhGR44M-5EGysUYJyVfcRoAiFUUQYZQCsAjIXkfTHm7TdT2QfjDBq9b5Ex6mRbkypzqlynoyDJbxdhKKH1_-mTD4LSsmDyIAKdPWD3p9SxPM1TfsjuxOERu5svk_z1mHXfMQpdR06f4kuCXl1dQemHrhwpHCXnkB6l5l4qe9qW6768yWgTiXAVR08NRkhEWNbkC_H_gPRiU4671XqzfcIuzj7_-HTOpzsUOLS2Gbkk8BlMIbpGVDLirrORurWt1iq2mEsRnrwOXoi-F9oowPxA6RgBBSVFDbaXT9nRsB7ic1aCDaaSnfSYMTXeBl_bAAbTr6gMBB0KVu9Z6mACGKd7Lq5d2mgY5bIYHIrBJTG424J9mN-ZFvxX6o8kqZmSoLHTA1QYNymM-5fCFOwNydnlPtPZwN0pRumajqF0wd4nCjJxXAD4qVMB2UBgWQvK4wUlmiYsh_e65CbXsHVCV5QkN7Iq2Nt5mN6kcrchrneJBrMLIxXO9llWvXnRkraA0uCP64VSLriyHBmufibgcCsNwSe--B9sfMnuiWRPhtfqmB2Nm118hfnZGF4nU_wNF8g2SQ priority: 102 providerName: Directory of Open Access Journals |
| Title | Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35974387 https://www.proquest.com/docview/2704057430 https://www.proquest.com/docview/2703418364 https://pubmed.ncbi.nlm.nih.gov/PMC9380328 https://doaj.org/article/78926c6173fe426cbb0e3b3bc76cc554 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagFRIXxJtAWYKExAFFTeLEjxNqUUuFRIWASnuz4olTKnWTsske6K9nxvGGRki97CGeZG3P67M9M2bsHUJaW9WpplNdR7tVNqk0lAnoQtSZdsrllJz89VScnBVfluUybLj1IaxyaxO9oa47oD3y_VymhC0Knn68-p3QrVF0uhqu0LjLdql0GYV0yeW04MJ-FHKbKKPEfp-RQCcUv04HQjy5njkjX7P_f8t8wzXNwyZv-KHjh-xBAJDxwcjxR-yOax-ze-OVkn-esPoH-qJLl9CGfEwFWFcXEFdtHQ_klLyJ8I98ii8FP_Vx18RXY80JT7hyQ0VpRkhEFa3JIuL_AUnHOh42q27dP2Vnx0c_P50k4SaFBEpdDAmnEjQIJOoiT7nDtWfBZalLKYUrEVFRVXlpqzxvmlwqAYgShHQOkF08z0A3_BnbabvWvWAxaKtSXvMKcVNRaVtl2oJCEOaEAittxLLtlBoIZcbptotL45cbSpiRDQbZYDwbzHXEPkzvhAHfSn1InJooqUC2f9Ctz03QNyOVzgUgPOONQxAC1qaOW25BCgCEUBF7Q3w2Y7bppObmAH11RodRMmLvPQUpOg4AqpCvgNNAJbNmlHszSlRQmDdvZckEA9Gbf-IcsbdTM71JQW-t6zaeBjGG4gJ7-3wUvWnQnBaCXOHH5UwoZ7Myb2kvfvny4ZorKqL48vZuvWL3c68pKsnEHtsZ1hv3GvHXYBdeyRZs9_Do9Nv3hd_FwN_Py-wvMA4xGg |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgguiDcLhQYJxAFFTezEjwNCLbTa0naFoJV6c2PHC5W6SdlkhdofxW9kxnnQCKm3XuNJYntenx8zQ8gbgLQmyyOFp7oOd6tMmCmbhlYlPI-Vk45icPLBlE-Oki_H6fEK-dPFwuC1ys4mekOdlxb3yDeoiBBbJCz6eP4rxKpReLraldBoxGLPXfyGJVv1Yfcz8PctpTvbh58mYVtVILSpSuqQYToWcKp5QiPmYB2WMJGqVAjuUkAXmGFdmIzS2YwKyS14TC6cs9B1RmOrZgy-e4usJgyWMiOyurU9_fqts_0w8kR0oTmSb1QxqlCIN-bxCIqFlwP356sE_O8LrjjD4UXNK55v5z6510LWYLORsQdkxRUPye2miOXFI5J_B-935kI8Aggw5ev81AZZkQc1ukFvlPwjH1SM162qoJwF502WC084d3WGgU1AhDm00QbD_yzK4yKol_NyUT0mRzcyy0_IqCgL94wEVhkZsZxlgNSSTJksVsZKgH2OS2uEGZO4m1Jt28TmWF_jTPsFjuS6YYMGNmjPBn05Ju_7d9oBX0u9hZzqKTElt39QLn7oVsO1kIpyC4CQzRzAHmtM5JhhxgpuLYC2MVlHPusmvrU3LHoT0EGMx19iTN55CjQtMACbtRESMA2YpGtAuTagBJNgh82dLOnWJFX6nwKNyeu-Gd_Ea3aFK5eeBlCNZBx6-7QRvX7QDJeeTMLHxUAoB7MybClOf_qE5YpJTNv4_PpurZM7k8ODfb2_O917Qe5SrzUyjPkaGdWLpXsJ6K82r1qVC8jJTWv5Xxi2aD8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single-cell+genomic+and+transcriptomic+landscapes+of+primary+and+metastatic+colorectal+cancer+tumors&rft.jtitle=Genome+medicine&rft.au=Wang%2C+Rui&rft.au=Li%2C+Jingyun&rft.au=Zhou%2C+Xin&rft.au=Mao%2C+Yunuo&rft.date=2022-08-16&rft.pub=BioMed+Central+Ltd&rft.issn=1756-994X&rft.eissn=1756-994X&rft.volume=14&rft.issue=1&rft_id=info:doi/10.1186%2Fs13073-022-01093-z&rft.externalDocID=A718165757 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-994X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-994X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-994X&client=summon |